Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of THERALINK TECHNOLOGIES, INC. from 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
THERALINK TECHNOLOGIES, INC. quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from 2018 to Q4 2023.
  • THERALINK TECHNOLOGIES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Dec 2023 was -$974K, a 232% decline year-over-year.
  • THERALINK TECHNOLOGIES, INC. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $604K, a 662% increase from 2022.
  • THERALINK TECHNOLOGIES, INC. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $79.3K.
  • THERALINK TECHNOLOGIES, INC. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was -$1.47M, a 220% decline from 2020.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

THERALINK TECHNOLOGIES, INC. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$974K -$1.71M -232% 01 Oct 2023 31 Dec 2023 10-Q 20 Feb 2024
Q4 2022 $737K +$637K +631% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024
Q4 2021 $101K +$1.34M 01 Oct 2021 31 Dec 2021 10-Q 21 Feb 2023
Q4 2020 -$1.24M -$2.39M -207% 01 Oct 2020 31 Dec 2020 10-Q 18 Feb 2022
Q1 2020 -$19.4K -$19.2K 01 Jan 2020 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $1.15M 01 Oct 2019 31 Dec 2019 10-Q 27 Sep 2021
Q1 2019 -$201* 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020

THERALINK TECHNOLOGIES, INC. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $604K +$525K +662% 01 Oct 2022 30 Sep 2023 10-K 05 Jan 2024
2022 $79.3K +$1.54M 01 Oct 2021 30 Sep 2022 10-K 05 Jan 2024
2021 -$1.47M -$2.68M -220% 01 Oct 2020 30 Sep 2021 10-K 29 Dec 2022
2020 $1.22M +$1.2M +5626% 01 Oct 2019 30 Sep 2020 10-K 13 Jan 2022
2019 $21.3K +$22.5K 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2020
2018 -$1.23K 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.